XML 82 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2016 $ 57 $ 272,432 $ (234) $ (236,387) $ 35,868
Balance (in shares) at Dec. 31, 2016 56,820,422   41,309    
Issuance of common stock in connection with exercise of warrants   2,142     2,142
Issuance of common stock in connection with exercise of warrants (in shares) 887,585        
Issuance of restricted stock $ 2 (2)      
Issuance of restricted stock (in shares) 1,836,511        
Forfeiture of restricted stock (in shares) (53,875)        
Issuance of common stock (net of offering costs) $ 6 53,634     53,640
Issuance of common stock (net of offering costs) (in shares) 5,897,436        
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 8 77,865     77,873
Compensation in respect of restricted stock granted to employees, directors and consultants   15,945     15,945
Net loss       (118,476) (118,476)
Balance at Dec. 31, 2017 $ 73 422,017 $ (234) (354,863) 66,993
Balance (in shares) at Dec. 31, 2017 73,181,750   41,309    
Issuance of common stock in At-the-Market offerings (in shares) 7,793,671        
Issuance of restricted stock $ 2 (2)      
Issuance of restricted stock (in shares) 1,562,211        
Forfeiture of restricted stock (in shares) (191,196)        
Issuance of common stock (net of offering costs) $ 9 113,630     113,639
Compensation in respect of restricted stock granted to employees, directors and consultants   12,886     12,886
Shares issued in connection with in-licensing agreements   4,000     4,000
Shares issued in connection with in-licensing agreements (in shares) 333,868        
Net loss       (173,482) (173,482)
Balance at Dec. 31, 2018 $ 84 552,531 $ (234) (528,345) 24,036
Balance (in shares) at Dec. 31, 2018 83,911,855   41,309    
Issuance of common stock in At-the-Market offerings (in shares) 9,025,222        
Issuance of restricted stock $ 1 (1)      
Issuance of restricted stock (in shares) 1,851,520        
Warrants issued with debt financing   993     993
Forfeiture of restricted stock (in shares) (116,463)        
Issuance of common stock (net of offering costs) $ 10 77,465     77,475
Issuance of common stock (net of offering costs) (in shares) 10,149,783        
Issuance of common stock in At-the-Market offerings (net of offering costs) $ 14 97,533     97,547
Compensation in respect of restricted stock granted to employees, directors and consultants   11,335     11,335
Shares issued in connection with in-licensing agreements   100     100
Shares issued in connection with in-licensing agreements (in shares) 8,383        
Net loss       (172,871) (172,871)
Balance at Dec. 31, 2019 $ 109 $ 739,956 $ (234) $ (701,216) $ 38,615
Balance (in shares) at Dec. 31, 2019 109,425,243   41,309    
Issuance of common stock in At-the-Market offerings (in shares) 13,620,165